Marcus Maurer
Charité - Universitätsmedizin Berlin
H-index: 132
Europe-Germany
Top articles of Marcus Maurer
Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)
2024/4/14
Sarbjit Saini
H-Index: 35
Jin Nakahara
H-Index: 16
Heinz Wiendl
H-Index: 55
Marcus Maurer
H-Index: 75
Tanuja Chitnis
H-Index: 51
Enhancing Angioedema Patient Care: Unveiling Underutilization and Barriers in the Implementation of Patient-Reported Outcome Measurements
Journal of Allergy and Clinical Immunology
2024/2/1
Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria
World Allergy Organization Journal
2024/1/1
Michael Levin
H-Index: 10
Marcus Maurer
H-Index: 75
Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany
Journal of the European Academy of Dermatology and Venereology
2024/3/5
A Patient Charter for Chronic Urticaria
Advances in Therapy
2024/1
Marcus Maurer
H-Index: 75
The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria (P10-6.018)
2024/4/14
Actual real-world application of PROMs in Asthma and Rhinitis as advised by guidelines: PROMUSE Respiratory Study
Journal of Allergy and Clinical Immunology
2024/2/1
Response to" Clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different …
Allergy
2024/1
Marcus Maurer
H-Index: 75
Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study
Clinical and Translational Allergy
2024/3
Nida Öztop
H-Index: 5
Marcus Maurer
H-Index: 75
Dupilumab Reduces Disease Activity in Patients with Chronic Spontaneous Urticaria: LIBERTY-CSU CUPID Study A
Journal of Allergy and Clinical Immunology
2024/2/1
Marcus Maurer
H-Index: 75
Sarbjit Saini
H-Index: 35
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights
The Journal of Allergy and Clinical Immunology: In Practice
2024/2/1
Marcus Maurer
H-Index: 75
The European Network for IgE-Mediated Autoimmunity and Autoallergy (ENIGMA) initiative
Nature Medicine
2024/3/1
Nicolas Charles
H-Index: 7
Marcus Maurer
H-Index: 75
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
The Journal of Allergy and Clinical Immunology: In Practice
2024/1/1
A core outcome set for efficacy of acute treatment of hereditary angioedema
The Journal of Allergy and Clinical Immunology: In Practice
2024/4/11
Green Roof Gardens–Selecting Allergy-Friendly Vegetation: A Global Allergy and Asthma Excellence Network (GA²LEN) Position Paper
2024/2/1
Marcus Maurer
H-Index: 75
Jean Bousquet
H-Index: 34
Analysis of safety data of remibrutinib from completed phase 2 studies in inflammatory immune-mediated diseases
Annals of Allergy, Asthma & Immunology
2023/11/1
Sarbjit Saini
H-Index: 35
Marcus Maurer
H-Index: 75
Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria
Journal of the European Academy of Dermatology and Venereology
2024/1
Fast symptom improvement and favorable safety profile with remibrutinib in chronic spontaneous urticaria: REMIX-1/-2 studies
Annals of Allergy, Asthma & Immunology
2023/11/1
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials
Journal of Allergy and Clinical Immunology
2024/2/29
Marcus Maurer
H-Index: 75
Kiran Patel
H-Index: 3
Urticaria Patients Are Highly Interested in Apps to Monitor Their Disease Activity and Control: A UCARE CURICT Analysis
2024/1/31
Co-Authors
